Crescent Biopharma Inc. – Material Contracts Watch

from 10-K 2 pages Crescent Biopharma, Inc. Amended and Restated Non-Employee Director Compensation Policy [Effective June 13, 2025]

from 10-K 13 pages [***] = Certain Confidential Information Contained in This Document, Marked by Brackets, Has Been Omitted Because the Information (I) Is Not Material and (II) Is the Type of Information That the Registrant Both Customarily and Actually Treats as Private and Confidential

from 10-K 7 pages Crescent Biopharma, Inc. 2025 Employment Inducement Incentive Award Plan Grant Notice for Stock Options

from 10-K 6 pages Crescent Biopharma, Inc. 2025 Stock Incentive Plan Grant Notice for Restricted Stock Unit Award

from 10-K 6 pages Crescent Biopharma, Inc. 2025 Stock Incentive Plan Grant Notice for Restricted Stock Unit Award

from 10-K 6 pages Crescent Biopharma, Inc. 2025 Stock Incentive Plan Grant Notice for Restricted Stock Unit Award

from 10-K 8 pages Crescent Biopharma, Inc. 2025 Stock Incentive Plan Grant Notice for Stock Options

from 10-K 8 pages Crescent Biopharma, Inc. 2025 Stock Incentive Plan Grant Notice for Stock Options

from 10-K 8 pages Crescent Biopharma, Inc. 2025 Stock Incentive Plan Grant Notice for Stock Options

from S-1 2 pages [***] = Certain Confidential Information Contained in This Document, Marked by Brackets, Has Been Omitted Because the Information (I) Is Not Material and (II) Is the Type of Information That the Registrant Both Customarily and Actually Treats as Private and Confidential

from S-1 2 pages [***] = Certain Confidential Information Contained in This Document, Marked by Brackets, Has Been Omitted Because the Information (I) Is Not Material and (II) Is the Type of Information That the Registrant Both Customarily and Actually Treats as Private and Confidential

from S-1 2 pages [***] = Certain Confidential Information Contained in This Document, Marked by Brackets, Has Been Omitted Because the Information (I) Is Not Material and (II) Is the Type of Information That the Registrant Both Customarily and Actually Treats as Private and Confidential

from S-1 2 pages [***] = Certain Confidential Information Contained in This Document, Marked by Brackets, Has Been Omitted Because the Information (I) Is Not Material and (II) Is the Type of Information That the Registrant Both Customarily and Actually Treats as Private and Confidential

from S-1 2 pages [***] = Certain Confidential Information Contained in This Document, Marked by Brackets, Has Been Omitted Because the Information (I) Is Not Material and (II) Is the Type of Information That the Registrant Both Customarily and Actually Treats as Private and Confidential

from S-1 2 pages [***] = Certain Confidential Information Contained in This Document, Marked by Brackets, Has Been Omitted Because the Information (I) Is Not Material and (II) Is the Type of Information That the Registrant Both Customarily and Actually Treats as Private and Confidential

from S-1 69 pages [***] = Certain Confidential Information Contained in This Document, Marked by Brackets, Has Been Omitted Because the Information (I) Is Not Material and (II) Is the Type of Information That the Registrant Both Customarily and Actually Treats as Private and Confidential. License and Collaboration Agreement by and Among Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd., Crescent Biopharma Operating Company, LLC, and Crescent Biopharma, Inc. Dated as of December 2, 2025 [***] = Certain Confidential Information Contained in This Document, Marked by Brackets, Has Been Omitted Because the Information (I) Is Not Material and (II) Is the Type of Information That the Registrant Both Customarily and Actually Treats as Private and Confidential

from S-1 63 pages Agreement

from S-1 40 pages [***] = Certain Confidential Information Contained in This Document, Marked by Brackets, Has Been Omitted Because the Information (I) Is Not Material and (II) Is the Type of Information That the Registrant Both Customarily and Actually Treats as Private and Confidential. License Agreement

from 8-K 21 pages Registration Rights Agreement

from 8-K 36 pages Securities Purchase Agreement